NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer. (2020)

First Author: O'Cathail SM
Attributed to:  Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cancergen.2020.08.006

PubMed Identifier: 32871287

Publication URI: http://europepmc.org/abstract/MED/32871287

Type: Journal Article/Review

Volume: 248-249

Parent Publication: Cancer genetics